A Study Assessing the Effects of Acupuncture in Parkinson's Disease Patients With Chronic Appendicitis

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Parkinson's Disease, Chronic Appendicitis, Acupuncture

In brief

The incidence of PD is high, and when the disease is serious to a certain extent, the effect of drugs to control symptoms decreases, resulting in a significant reduction in the quality of life of patients. Recent studies have found that these PD symptoms are closely related to the intestine. For several cases of PD syndrome patients complicated with chronic appendicitis, our research group conducted acupuncture on points related to constipation and chronic appendicitis, and found that constipation and related motor symptoms of patients could be significantly improved. Clinical studies have shown that acupuncture also has a certain therapeutic effect on non-motor symptoms of Parkinson's disease, such as anxiety and depression, decreased olfactory function, sleep disorders, constipation, early skeletal muscle pain, cognitive dysfunction, etc., which can delay the progression of the disease and improve the quality of life of patients. Starting from intestinal acupuncture, this project further clarified the role of acupuncture treatment in the comprehensive treatment of PD

Key facts

Study ID

NCT06304285

Run by

The First Affiliated Hospital of University of Science and Technology of China

People needed

84

Starts

2024-03-01

Expected to finish

2026-12-31

Last updated by the study team

2024-03-12

Who can join

Age: 40 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients presenting with bradykinesia, combined with resting tremor and/or myotonia.
• Appendix CT suggested chronic appendicitis evaluated by two experienced experts.
• All subjects and their guardians give informed consent to the content of this study and sign informed consent.
• Normal coagulation function.
• If the patient had taken oral anti-PD drugs, it had been stable for at least 2 weeks at enrollment.

You may not qualify if…

• Treatment with dopamine blockers or dopamine depleters in doses and time courses consistent with drug-induced parkinsonism.
• Neuroimaging examination of presynaptic dopaminergic system function was normal.
• Patients who had suffered severe brain trauma or underwent complex craniotomy within 5 years prior to enrollment.
• Cognitive disorders that are not on the Parkinson's spectrum, such as Alzheimer's disease, frontotemporal dementia, and Niemann-Pick disease, have been diagnosed.
• People diagnosed with severe neuropsychiatric disorders (epilepsy, bipolar disorder, major depressive episode, etc.) according to DSM-V.
• Complicated with serious systemic diseases, disorders of consciousness, stroke, serious coronary heart disease, diabetes, liver and kidney diseases, and serious visual and hearing disorders.
• Patients with severe organic or functional dysphagia;Those who were deemed by the researcher to be unable to complete the visit and auxiliary examination as required by the study protocol.

Where it is running

• The First Affiliated Hospital of University of Science and Technology of China — Hefei, Anhui, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.